Third, the specific target antigen responsible for PLA2R-negative MN in this case remains unidentified, as comprehensive testing for other MN-associated antigens (e.g., THSD7A, NELL-1) was not performed, potentially constraining our understanding of the triggering factors for anti-GBM disease in this context. This evidence concerns the gene PLA2R1 and glioblastoma.